| FEFAX | FWWMX | FEFAX / FWWMX | |
| Total Expense Ratio | 0.90 | 0.31 | 290% |
| Annual Report Gross Expense Ratio | 1.07 | 0.31 | 345% |
| Fund Existence | 27 years | 5 years | - |
| Gain YTD | 20.715 | 11.480 | 180% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 444M | 209B | 0% |
| Annual Yield % from dividends | 0.93 | 1.41 | 66% |
| Returns for 1 year | 9.50 | 5.28 | 180% |
| Returns for 3 years | 49.71 | 33.88 | 147% |
| Returns for 5 years | 11.73 | 51.47 | 23% |
| Returns for 10 years | -8.56 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PPH | 99.33 | 1.13 | +1.15% |
| VanEck Pharmaceutical ETF | |||
| XYLG | 29.51 | 0.02 | +0.08% |
| Global X S&P 500® Covered Call & Gr ETF | |||
| JANU | 28.19 | 0.02 | +0.08% |
| AllianzIM U.S. Equity Buffer15 Uncapped Jan ETF | |||
| NOCT | 57.44 | -0.07 | -0.11% |
| Innovator Growth-100 Pwr Buff ETF™ Oct | |||
| ERNZ | 20.96 | -0.03 | -0.14% |
| TrueShares Active Yield ETF | |||